Pulmonary endarterectomy and the cost of patient refusal
- PMID: 30220650
- DOI: 10.1183/13993003.01581-2018
Pulmonary endarterectomy and the cost of patient refusal
Conflict of interest statement
Conflict of interest: N.K. Kim reports personal fees from Actelion and Bayer (speaker bureau, steering committee and consultant fees), personal fees from Merck (consultant fees), support from the International CTEPH Association (as a board member), and personal fees from CTEPH.com (as a board member), outside the submitted work. Conflict of interest: E. Mayer reports personal fees from Actelion, Bayer and MSD (speaker's and consulting fees), and from Pfizer (speaker's fees), during the conduct of the study.
Comment in
-
Decision-making in pulmonary endarterectomy surgery.Eur Respir J. 2019 Jan 10;53(1):1801973. doi: 10.1183/13993003.01973-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30630852 No abstract available.
-
Decision-making in pulmonary endarterectomy surgery.Eur Respir J. 2019 Jan 10;53(1):1802138. doi: 10.1183/13993003.02138-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30630853 No abstract available.
Comment on
-
The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension.Eur Respir J. 2018 Sep 16;52(3):1800589. doi: 10.1183/13993003.00589-2018. Print 2018 Sep. Eur Respir J. 2018. PMID: 30002102 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical